 |
|
|
| |
Efficacy and Inflammatory Markers After
144 Weeks of Switch to DTG/3TC in a Randomized Trial
|
| |
| |
CROI 2025 SF March 9-12
Evy E. Blomme1, Evelien De Smet1, Elianne Burg1, Loïc Schrooyen1, Sophie Degroote2, Sophie Vanherrewege2, Els Caluwe2, Linos Vandekerckhove1,2, Sarah Gerlo1,3, Marie-Angélique De Scheerder2
1HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium, 2Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium 3Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
|
| |
|
|
|
|
|
